Thank you - Your Download is Available Below
Development of an End-to-End Scalable Purification Platform for Extracellular Vesicles
Extracellular vesicles (EVs) are being evaluated as novel therapeutics for a variety of diseases due to low immunogenicity, low toxicity, and increased circulation stability. However, the characterization and purification of EVs is quite challenging. Sartorius, a frontrunner in EV process development, provides end-to-end solutions and expertise for EV production, purification, and characterization.
- Robust analytical platform for EV characterization
- Robust purification to maximize yield and purity
- Process expertise and consulting